Stockreport

Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL® (propranolol hydrochloride) Oral Solution

Eton Pharmaceuticals, Inc.  (ETON) 
Last eton pharmaceuticals, inc. earnings: 3/5 04:02 pm Check Earnings Report
PDF HEMANGEOL® is the only FDA-approved treatment for infantile hemangiomaHEMANGEOL will be commercialized by Eton beginning May 1stHEMANGEOL will be distributed through the [Read more]